Raised in 2018
CKC focuses on funding the most promising clinical trials at Seattle Children’s Hospital. Clinical trials are how we go from curing mice with cancer, to curing children with cancer – in innovative new ways that don’t have the dire outcomes of current protocols. We’re targeting a very specific and very practical study where we make a huge impact. Currently, we are funding clinical trials for adaptive T-Cell immunotherapy used for the treatment of pediatric cancer.